رجوع
نطاق اليوم
KWD 16.27
KWD 16.28
نطاق 52 أسبوعًا
KWD 11.65
KWD 18.61
حجم التداول
1,761,004
متوسط 50 يوم / 200 يوم
KWD 15.60
/
KWD 14.35
الإغلاق السابق
KWD 16.27
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 13.8 | 0.3 |
| P/B | 1.2 | 2.9 |
| ROE % | 8.6 | 3.7 |
| Net Margin % | 2.7 | 3.8 |
| Rev Growth 5Y % | -3.2 | 10.0 |
| D/E | 2.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 18.000
+10.6%
Low: KWD 17.000
High: KWD 19.000
مكرر الربحية المستقبلي
12.9
ربحية السهم المستقبلية
KWD 1.258
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
5.7 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 1.507
KWD 1.233 – KWD 1.781
|
6.2 B | 2 |
| FY2027 |
KWD 1.394
KWD 1.297 – KWD 1.452
|
6 B | 4 |
| FY2026 |
KWD 1.258
KWD 1.239 – KWD 1.288
|
5.7 B | 4 |
النقاط الرئيسية
Revenue declined -3.18% annually over 5 years
Earnings declined -31.69% over the past year
Debt/Equity of 2.17 — high leverage
Generating 382.74M in free cash flow
P/E of 13.80 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.30%
النمو
Revenue Growth (5Y)
-3.18%
Revenue (1Y)5.12%
Earnings (1Y)-31.69%
FCF Growth (3Y)4.15%
الجودة
Return on Equity
8.63%
ROIC4.64%
Net Margin2.68%
Op. Margin6.14%
الأمان
Debt / Equity
2.17
Current Ratio1.04
Interest Coverage2.85
التقييم
P/E Ratio
13.80
P/B Ratio1.18
EV/EBITDA17.02
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.12% | Revenue Growth (3Y) | -9.54% |
| Earnings Growth (1Y) | -31.69% | Earnings Growth (3Y) | -22.51% |
| Revenue Growth (5Y) | -3.18% | Earnings Growth (5Y) | -22.35% |
| Profitability | |||
| Revenue (TTM) | 5.45B | Net Income (TTM) | 146.22M |
| ROE | 8.63% | ROA | 2.50% |
| Gross Margin | 11.54% | Operating Margin | 6.14% |
| Net Margin | 2.68% | Free Cash Flow (TTM) | 382.74M |
| ROIC | 4.64% | FCF Growth (3Y) | 4.15% |
| Safety | |||
| Debt / Equity | 2.17 | Current Ratio | 1.04 |
| Interest Coverage | 2.85 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 13.80 | P/B Ratio | 1.18 |
| P/S Ratio | 0.37 | PEG Ratio | -0.43 |
| EV/EBITDA | 17.02 | Dividend Yield | 0.02% |
| Market Cap | 2.02B | Enterprise Value | 5.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.45B | 5.19B | 6.66B | 6.33B | 6.20B |
| Net Income | 146.22M | 214.04M | 243.49M | 158.99M | 402.23M |
| EPS (Diluted) | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 |
| Gross Profit | 629.30M | 633.64M | 932.04M | 733.38M | 919.37M |
| Operating Income | 334.58M | 268.32M | 554.87M | 403.28M | 713.77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.85B | 5.61B | 7.69B | 7.67B | 7.36B |
| Total Liabilities | 3.82B | 3.61B | 6.12B | 6.27B | 6.00B |
| Shareholders' Equity | 1.71B | 1.68B | 1.29B | 1.12B | 1.11B |
| Total Debt | 3.70B | 2.70B | 4.52B | 5.16B | 4.76B |
| Cash & Equivalents | 26.52M | 59.69M | 52.63M | 97.91M | 74.31M |
| Current Assets | 1.03B | 1.02B | 1.26B | 1.27B | 1.14B |
| Current Liabilities | 984.49M | 977.65M | 1.25B | 1.16B | 1.27B |